Uncategorized Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis – PMC January 6, 2025 dashephe https://pmc.ncbi.nlm.nih.gov/articles/PMC6760417/